These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9065646)

  • 1. A comparative study of undifferentiated nasopharyngeal carcinoma treated with radiotherapy or combined treatment with zorubicin-cisplatin and radiotherapy.
    Pendjer I; Krejovic B; Vucicevic S
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S127-9. PubMed ID: 9065646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type.
    Azli N; Armand JP; Rahal M; Wibault P; Boussen H; Eschwege F; Schwaab G; Gasmi J; Bachouchi M; Cvitkovic E
    Eur J Cancer; 1992; 28A(11):1792-7. PubMed ID: 1382499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
    Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
    Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
    Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
    J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
    Chan AT; Ma BB; Lo YM; Leung SF; Kwan WH; Hui EP; Mok TS; Kam M; Chan LS; Chiu SK; Yu KH; Cheung KY; Lai K; Lai M; Mo F; Yeo W; King A; Johnson PJ; Teo PM; Zee B
    J Clin Oncol; 2004 Aug; 22(15):3053-60. PubMed ID: 15284255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy of alternating chemo-radiotherapy for locally advanced nasopharyngeal carcinoma].
    You X; Yang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):376-80. PubMed ID: 24961123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy.
    Jian JJ; Cheng SH; Tsai SY; Yen KC; Chu NM; Chan KY; Tan TD; Cheng JC; Lin YC; Leu SY; Hsieh CI; Tsou MH; Lin CY; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):344-52. PubMed ID: 12023138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Hsu CY
    Am J Clin Oncol; 1996 Dec; 19(6):624-7. PubMed ID: 8931685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
    Farrell PJ
    Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
    [No Abstract]   [Full Text] [Related]  

  • 16. Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer.
    Lin JC; Jan JS; Hsu CY
    Am J Clin Oncol; 1997 Feb; 20(1):6-10. PubMed ID: 9020279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.
    Wolden SL; Zelefsky MJ; Kraus DH; Rosenzweig KE; Chong LM; Shaha AR; Zhang H; Harrison LB; Shah JP; Pfister DG
    J Clin Oncol; 2001 Feb; 19(4):1105-10. PubMed ID: 11181675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
    Chen M; Lin S; Zheng W
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.
    Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T
    Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
    Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.